Status:
UNKNOWN
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
Lead Sponsor:
C.R.Darnall Army Medical Center
Conditions:
Migraine Headache
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
: Headaches are a common complaint presenting to the emergency department (ED), accounting for 1-2% of all ED visits, with migraines as the second most common primary headache syndrome. Patients that ...
Detailed Description
A urine pregnancy test will be performed on women of child bearing age. After informed consent is obtained, each patient will be placed in a dark private room and asked to grade nausea, pain, and seda...
Eligibility Criteria
Inclusion
- Migraine Headache
Exclusion
- Pregnancy and lactation,
- Pre-medication within six hours of being enrolled in the study,
- More than six prior headaches per month,
- Allergy to the study drugs,
- Non-migraine headache,
- Substance abuse,
- Alcohol abuse,
- Diabetes mellitus, or a coexisting condition that might expose the patients to a disproportionately increased risk of a significant adverse event: ischaemic heart disease, peripheral vascular disease, cerebrovascular disease, uncontrolled hypertension (blood pressure \>160/95), epilepsy, use of cimetidine, dopamine agonist, cyclopsorin, or oral hypoglycemic agents, hepatic or renal failure, and thyroid disorder.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00274170
Start Date
January 1 2006
End Date
February 1 2007
Last Update
March 1 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CR Darnall Army Medical Center
Fort Hood, Texas, United States, 76544